CDK inhibition
Showing 51 - 75 of 2,996
Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial
Not yet recruiting
- Aggressive B-Cell Non-Hodgkin's Lymphoma
- +4 more
- (no location specified)
Dec 16, 2022
Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in
Recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- +2 more
-
Duarte, California
- +2 more
Aug 29, 2022
Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)
Active, not recruiting
- Metastatic Breast Cancer
-
Hospitalet de Llobregat, Barcelona, Spain
- +6 more
Jan 23, 2023
Breast Cancer Trial in New York (Multicomponent Adherence Intervention)
Recruiting
- Breast Cancer
- Multicomponent Adherence Intervention
-
New York, New YorkColumbia University Medical Center
Nov 6, 2023
Tumors Trial in Seoul (abemaciclib+paclitaxel)
Active, not recruiting
- Tumors
-
Seoul, Korea, Republic ofSeverance Hospital
May 30, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Bithalamic High Grade Glioma Trial in Cincinnati (Ribociclib)
Terminated
- High Grade Glioma
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 15, 2020
HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Worldwide (palbociclib, trastuzumab, pertuzumab)
Active, not recruiting
- HER-2 Positive Breast Cancer
- Estrogen Receptor Positive Breast Cancer
- palbociclib
- +6 more
-
San Francisco, California
- +106 more
Mar 16, 2022
Cutaneous T-cell Lymphoma (CTCL) Trial in United Kingdom (CDK-003)
Recruiting
- Cutaneous T-cell Lymphoma (CTCL)
- CDK-003
-
Birmingham, United Kingdom
- +3 more
Apr 22, 2022
Head and Neck Squamous Cell Carcinoma Trial in Taipei (Ribociclib, Spartalizumab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 19, 2022
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021
Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)
Active, not recruiting
- Breast Cancer
- Ribociclib
- +3 more
-
Casale Monferrato, AL, Italy
- +40 more
Dec 3, 2021
Breast Cancer, Solid Tumor, Adult Trial in United States (APG-2575, Palbociclib)
Recruiting
- Breast Cancer
- Solid Tumor, Adult
-
Atlanta, Georgia
- +3 more
Aug 12, 2022
Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)
Active, not recruiting
- Solid Neoplasm
- +16 more
- Carboplatin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Breast Cancer Trial in Boston (Abemaciclib)
Terminated
- Breast Cancer
-
Boston, MassachusettsDana-Farber Cancer Institute
Oct 3, 2022
Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations Trial in Worldwide (Neratinib, Fulvestrant, Trastuzumab)
Active, not recruiting
- Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
- Neratinib
- +2 more
-
Birmingham, Alabama
- +59 more
Mar 3, 2022
NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Ipilimumab
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoek - Netherlands Cancer Institute
Jan 10, 2023
Piriformis Syndrome Trial in Lahore (muscle energy technique, stretching exercise)
Recruiting
- Piriformis Syndrome
- muscle energy technique
- stretching exercise
-
Lahore, Punjab, PakistanLady Willington
Jun 14, 2023
Endogenous Analgesia in Patients With Chronic Knee Pain
Recruiting
- Chronic Pain
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Pain Medicine at Centre Commons
Jan 9, 2023
Renal Insufficiency, Chronic Trial in Bogotá (CKD SMS)
Recruiting
- Renal Insufficiency, Chronic
- CKD SMS
-
Bogotá, Cundinamarca, ColombiaJudith Medellin Olaya
Jan 28, 2023
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)
Active, not recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Miami, Florida
- +21 more
Mar 18, 2022
Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane
Recruiting
- Metastatic Breast Cancer
- Enobosarm & Abemaciclib Combo
- non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
-
Chandler, Arizona
- +29 more
Feb 1, 2023
Young Adults Trial in Providence (Transcranial direct current stimulation)
Recruiting
- Young Adults
- Transcranial direct current stimulation
-
Providence, Rhode IslandButler Hospital
Dec 1, 2022